malignant lesions

Related by string. malignant lesion * Malignant : malignant brain tumor . remove malignant tumor . discovered malignant pancreatic . malignant transformation . malignant melanoma . malignant melanomas / Lesions . Lesion . lesioned : target lesion revascularization . metastatic lesions . benign lesions . pigmented lesions rejuvenate . precursor lesions * pre malignant lesions *

Related by context. All words. (Click for frequent words.) 77 breast lesions 75 benign lesions 74 lung nodules 72 EUS FNA 72 hamartomas 71 renal tumors 71 malignant nodules 71 advanced adenomas 71 contralateral breast 70 precursor lesions 70 mucinous 70 mammographically 70 carotid stenosis 69 malignant polyps 69 leiomyomas 69 nodal metastases 69 lymph node metastases 69 extracapsular extension 68 SLNB 68 urothelial carcinoma 68 pulmonary nodules 68 neoplasms 68 prostate cancer CaP 68 FDG-PET/CT 68 renal cell carcinomas 68 metastatic lesions 68 nonmelanoma skin cancers 68 carcinoid tumor 68 cytoreductive surgery 68 conventional angiography 68 breast carcinomas 68 radical nephrectomy 68 pulmonary metastases 68 proximal colon 68 extracolonic findings 68 neoplasm 67 axillary node dissection 67 CIN3 + 67 adenomatous 67 lymphovascular invasion 67 urine cytology 67 adenoma 67 epithelial tumors 67 thyroid nodules 67 immunohistochemical staining 67 axillary lymph node 67 malignant prostate 67 histologically 67 PCa 67 adenomatous polyps 67 lymphadenopathy 67 advanced adenoma 67 catheter angiography 67 CIN2 + 67 plain radiographs 67 node metastases 67 schwannomas 67 FDG uptake 67 axillary lymph nodes 67 invasive carcinoma 67 resections 67 core needle biopsy 67 underwent resection 67 invasive carcinomas 66 sentinel nodes 66 lymph node involvement 66 malignant growths 66 sentinel lymph nodes 66 atypical hyperplasia 66 distant metastasis 66 pCR 66 neoplasias 66 colorectal neoplasms 66 GISTs 66 cervical lesions 66 axillary nodes 66 hyperplastic 66 sonographic findings 66 histopathologic 66 breast carcinoma 66 adnexal masses 66 pituitary adenomas 66 lobular carcinoma 66 occult metastases 66 lung lesions 66 ASCUS 66 rebleeding 66 CIN3 66 K ras mutations 66 hyperplastic polyps 66 supratentorial 66 excisional biopsy 66 adrenalectomy 66 paragangliomas 65 benign nodules 65 lymph node metastasis 65 meningiomas 65 transurethral resection 65 microcalcifications 65 cervical lymph nodes 65 adnexal mass 65 invasive coronary angiography 65 CP CPPS 65 pT3 65 sentinel lymph node biopsy 65 Hurthle cell 65 sentinel lymph node 65 coronary artery stenosis 65 leiomyoma 65 fibroadenoma 65 axillary dissection 65 Papillary 65 thyroid nodule 65 pelvic lymphadenectomy 65 premalignant lesions 65 osteosarcomas 65 carcinoids 65 B7 H3 65 Radical prostatectomy 65 micrometastasis 65 calcified plaques 65 neoplastic lesions 65 intestinal metaplasia 65 #F FDG PET 65 endometrial carcinoma 65 pathologic examination 65 NMIBC 65 angiographically 65 nodal metastasis 65 pT2 65 colorectal carcinoma 65 metastatic lymph nodes 65 endosonography 65 MGUS 65 lymph node removal 65 contralateral breast cancer 65 malignant neoplasms 65 pre malignant lesions 65 osteoid 65 microbleeds 65 hamartoma 65 hepatic lesions 65 thyroglobulin 65 gastric adenocarcinoma 65 locoregional recurrence 65 liver metastasis 65 metastases 65 varicoceles 65 radical prostatectomy RP 65 curative resection 65 FDG PET 65 carcinoid 65 invasive ductal 65 lesions 65 papillary 65 malignant ovarian 65 bladder cancers 65 SUVmax 65 helical CT 65 cerebral angiography 64 F FDG PET 64 proton MR spectroscopy 64 Sjögren syndrome 64 sonographically 64 ADPKD 64 basal cell carcinoma BCC 64 PSA nadir 64 MR arthrography 64 cytologic 64 intraobserver 64 varices 64 histologic examination 64 metachronous 64 KRAS mutations 64 skeletal metastases 64 gadolinium enhanced 64 ultrasonographic 64 transrectal ultrasound guided 64 #.#ng/ml 64 neoplastic 64 CIN2 64 Computed tomography 64 distant metastases 64 carcinomas 64 KRAS mutation 64 EGFR mutations 64 colonic polyps 64 thyroid carcinoma 64 hepatocellular carcinomas 64 lipomas 64 hypoperfusion 64 HER2 amplification 64 clinicopathological features 64 breast biopsies 64 serous ovarian cancer 64 revascularization procedures 64 chromosomal rearrangement 64 gastric cancers 64 BRCA2 mutation carriers 64 colonography 64 advanced neoplasia 64 transvaginal sonography 64 pelvic lymph nodes 64 Adenomas 64 tissue biopsies 64 surgical excision 64 wedge resection 64 intracranial hemorrhage ICH 64 biochemical recurrence 64 endometrial cancers 64 neuroendocrine carcinoma 64 coronary stenosis 64 histological subtype 64 colorectal tumors 64 sCJD 64 intraoperative complications 64 molecular subtypes 64 pre cancerous polyps 64 adenocarcinomas 64 BRCA1 mutation carriers 64 transesophageal echocardiography 64 spinal metastases 64 lymphadenectomy 64 micrometastases 64 acute aortic dissection 64 FDG PET imaging 64 histologic 64 bone scintigraphy 64 percutaneous biopsy 63 gastroduodenal 63 underwent surgical resection 63 sonographic appearance 63 osteoid osteoma 63 pericardial effusion 63 endoscopic ultrasonography 63 immunohistochemical analysis 63 polypoid 63 tumor recurrence 63 TKAs 63 HER2 expression 63 ovarian malignancy 63 malignant neoplasm 63 needle aspiration 63 neurologic complications 63 tumoral 63 enhanced sonography 63 histologic subtype 63 renal artery stenosis 63 T1 weighted images 63 differentiated thyroid 63 extracranial 63 basal cell cancers 63 histologic findings 63 malignant lymph nodes 63 colorectal polyp 63 postoperative chemotherapy 63 specific antigen PSA 63 optical colonoscopy 63 seminal vesicle invasion 63 PSADT 63 pancreatic adenocarcinoma 63 preoperative staging 63 dysplastic lesions 63 coronary stenoses 63 intracranial aneurysms 63 sarcomatoid 63 preoperative chemotherapy 63 hepatic metastases 63 metastatic neuroendocrine tumors 63 grade cervical intraepithelial 63 squamous 63 prostate carcinoma 63 osteochondromas 63 choroidal neovascularization 63 lung metastasis 63 malignant lesion 63 biopsy specimens 63 obstructive coronary artery 63 fibroma 63 histopathologic examination 63 lobular carcinomas 63 Squamous 63 fibroadenomas 63 angiography CTA 63 precancers 63 pseudoaneurysm 63 duplex ultrasonography 63 N. gonorrhoeae 63 neoplasia 63 ductal carcinomas 63 mediastinoscopy 63 biochemical relapse 63 postoperative complication 63 BRAF mutations 63 noncancerous cells 63 adrenal masses 63 peritoneal carcinomatosis 63 benign polyps 63 DCIS lesions 63 melanoma lesions 63 Postoperative complications 63 fine needle aspiration 63 oncologic outcomes 63 perfusion abnormalities 63 perioperative mortality 63 pleural fluid 63 uveal melanoma 63 histological subtypes 63 ALND 63 HER2 overexpression 63 polypoid lesions 63 LVNC 63 sentinel node 63 submucosal 63 abdominal computed tomography 63 liver resection 63 grade dysplasia 63 clinically localized prostate 63 pathologic diagnosis 63 radiographic findings 63 cystic lesions 63 prostate carcinomas 63 stenoses 63 EBUS 63 Doppler sonography 63 neurofibromas 63 pulmonary angiography 63 clinicopathologic 63 ductal cancer 63 core needle biopsies 63 situ LCIS 63 thrombotic complications 62 salpingo oophorectomy 62 scintigraphic 62 ependymomas 62 postoperative mortality 62 resectable 62 pelvic ultrasound 62 situ CIS 62 mediastinal 62 nodular melanoma 62 chest radiographs 62 ischemic lesions 62 telangiectasia 62 calculi 62 coronary computed tomography 62 computed tomographic 62 postoperative pathology 62 axillary node 62 mediastinal lymph nodes 62 immunohistochemical 62 cancerous lesions 62 retroperitoneal 62 recurrent NSCLC 62 transcranial Doppler 62 hepatectomy 62 conventional coronary angiography 62 digital rectal examination 62 endoscopic resection 62 histologic subtypes 62 hematopoietic cancers 62 axillary lymph node dissection 62 premalignant 62 adrenocortical cancer 62 repigmentation 62 prostate biopsy 62 ovarian carcinoma 62 chemoembolization 62 liver metastases 62 needle biopsies 62 mesotheliomas 62 surgical biopsy 62 precancerous cervical 62 papillary thyroid carcinoma 62 renal biopsy 62 radiochemotherapy 62 hematuria 62 BCR ABL mutations 62 PROLARIS 62 metaplasia 62 Preoperative 62 seminomas 62 HER2 positive cancers 62 NP CRNs 62 upper endoscopy 62 microvascular complications 62 T1a 62 malignant pleural mesothelioma 62 postoperative morbidity 62 perioperative complications 62 eosinophilia 62 micro calcifications 62 malignancy 62 Histologically 62 parenchymal 62 unresectable tumors 62 metastatic tumors 62 ruptured aneurysms 62 lung metastases 62 lymph node dissection 62 hydronephrosis 62 nonmalignant 62 infarcts 62 atrophic gastritis 62 pulmonary infiltrates 62 cervical intraepithelial neoplasia 62 infiltrative 62 invasive angiography 62 PET CT scans 62 Computed tomographic 62 thymoma 62 histopathologic findings 62 recurrent VTE 62 preoperative diagnosis 62 papillary carcinoma 62 pheochromocytoma 62 colorectal adenocarcinoma 62 benign moles 62 thoracoscopic lobectomy 62 PR interval prolongation 62 FluCAM arm 62 nephrectomy 62 hypervascular 62 subtrochanteric 62 Recurrences 62 cancerous enlargement 62 biliary strictures 62 neurofibroma 62 pleomorphic 62 EBRT 62 Immunohistochemistry 62 LTBI 61 serum PSA 61 biopsies 61 immunostaining 61 denervation 61 BRAF mutation 61 neurologic symptoms 61 cTnT 61 axilla 61 pancreatic lung 61 neoadjuvant chemotherapy 61 lymphocytic 61 neovascular 61 serrated polyps 61 locoregional 61 posterior vitreous detachment 61 debulking surgery 61 lethal arrhythmias 61 subconjunctival hemorrhage 61 EBUS FNA 61 somatic mutations 61 cardiac computed tomography 61 T2 weighted MRI 61 splenic 61 lobular 61 obstructive CAD 61 colectomy 61 histologically confirmed 61 osteoporotic vertebral compression fractures 61 preoperatively 61 artery stenosis 61 epithelial ovarian cancer 61 lung nodule 61 gastrectomy 61 digital subtraction angiography 61 cystoscopic 61 microscopic hematuria 61 colorectal neoplasia 61 ultrasound elastography 61 abnormal cytology 61 noncardiac 61 choroidal neovascularization CNV 61 histologic diagnosis 61 lobular cancer 61 biopsy specimen 61 cholangiocarcinoma 61 gene amplification 61 morphologic 61 histological examination 61 patients undergoing CABG 61 follicular thyroid cancer 61 echogenicity 61 hyperintense lesions 61 extracolonic 61 lumbar disk herniation 61 nodal dissection 61 prostate adenocarcinoma 61 bladder tumors 61 chronic periodontitis 61 benign growths 61 parathyroid 61 ipsilateral breast 61 melanocytic lesions 61 sonographically guided 61 ecchymosis 61 TMPRSS2 ERG 61 chest radiography 61 prognostic significance 61 biochemical abnormalities 61 histological diagnosis 61 thrombi 61 cytologically confirmed 61 tumor necrosis 61 radiotherapy RT 61 transthoracic 61 pigmented skin lesions 61 CD# expression [001] 61 obstructive coronary 61 nondiagnostic 61 intact parathyroid hormone 61 hyperalgesia 61 CEUS 61 postoperative atrial fibrillation 61 segmentectomy 61 pulmonary emboli 61 microsatellite instability 61 detecting polyps 61 adjuvant radiotherapy 61 HGPIN 61 aortic regurgitation 61 lumbosacral spine 61 cutaneous lesions 61 hippocampal atrophy 61 papillomas 61 androgen deprivation 61 #F FDG 61 hypertrophic scars 61 BSGI 61 hypervascular tumors 61 X ray angiography 61 cystectomy 61 hypercoagulable 61 squamous cell cancers 61 conventional colonoscopy 61 diskectomy 61 adjuvant radiation 61 ovarian tumors 61 basal cell carcinomas 61 colorectal liver metastases 61 invasive ductal carcinoma 61 asymptomatic carotid stenosis 61 TRUS 61 atherosclerotic lesions 61 dysplastic nevi 61 node dissection 61 malignant lymphoma 61 esophagogastroduodenoscopy 61 T2 lesions 61 endometrial hyperplasia 61 transfusion syndrome 61 HER2 positive tumors 60 EGFR mutation 60 diagnostic modality 60 IgA deficiency 60 pseudoaneurysms 60 T1 weighted 60 incidentalomas 60 completely resected 60 Colon polyps 60 MACCE 60 ductal lobular 60 cervical carcinoma 60 localized renal 60 Aspergillus infections 60 anterior uveitis 60 prognostically 60 endobronchial 60 malignancies 60 colonoscopic 60 intravesical therapy 60 malignant tissue 60 transmural 60 RALP 60 haematuria 60 endometrioid 60 Immunohistochemical staining 60 hemorrhagic complications 60 varicocele 60 PCNSL 60 pancreatic carcinoma 60 colorectal adenoma 60 ductal 60 F FDG uptake 60 computed tomography scans 60 sentinel node biopsy 60 bacteriuria 60 definite stent thrombosis 60 postoperative infection 60 gastric carcinoma 60 tracer uptake 60 prostate TURP 60 prognostic variables 60 cutaneous melanoma 60 precancerous polyp 60 surgical biopsies 60 Cholangiocarcinoma 60 fibrocystic 60 heterotopic bone 60 cytological 60 brain parenchyma 60 opacification 60 osteochondroma 60 intraoperatively 60 coronary arteriography 60 resected 60 symptomatic VTE 60 intrathoracic 60 dimensional computed tomography 60 serum prostate 60 tricuspid regurgitation 60 sensitivity specificity 60 Breast Specific Gamma 60 cardiac troponin T 60 prophylactic cranial irradiation 60 computed tomography angiography 60 estrogen receptor ER 60 ventricular tachyarrhythmia 60 renal pelvis 60 NSCLC tumors 60 Biopsies 60 femoral neck fracture 60 dysplastic lesions caused 60 prostatic tissue 60 malperfusion 60 mitomycin C 60 HER2 positivity 60 chest radiograph 60 myocardial viability 60 pneumonectomy 60 vertebral fracture 60 renal cortical 60 superficial bladder cancer 60 nephron sparing surgery 60 aerodigestive tract 60 histopathological 60 chromosomal aberrations 60 bilateral oophorectomy 60 coronary lesions 60 CT angiograms 60 BSGI MBI 60 atypical ductal hyperplasia 60 elevated LDH 60 Circulating tumor cells 60 TOP2A 60 atypia 60 fluorodeoxyglucose positron emission tomography 60 carcinoembryonic antigen 60 mesenteric 60 anaplastic 60 p# biomarker 60 HIV HCV coinfected 60 Ultrasonography 60 nonproliferative 60 pre cancerous lesions 60 NPM1 mutation 60 CT angiogram 60 OAB symptoms 60 urethral strictures 60 lymphocytosis 60 radioiodine therapy 60 melanocytic 60 melanocytic nevi 60 laser photocoagulation 60 carcinoid tumors 60 MSCT 60 IDH1 mutation 60 hepatocellular 60 cystoscopy 60 renal parenchyma 60 ALK mutations 60 EBV infection 60 TRAIL R1 60 alkaline phosphatase ALP 60 nasal obstruction 60 NMP# assay 60 operable breast cancer 60 carotid artery stenosis 60 spiral computed tomography 60 mammographic 60 liposarcoma 60 hematologic toxicity 60 leukocytosis 60 neuroendocrine tumors 60 perfusion defects 60 proliferative diabetic retinopathy 60 normal karyotype 60 neuroblastomas 60 arteriography 60 cCTA 60 arthrography 60 R0 resection 60 CYT# potent vascular disrupting 60 KRAS mutations occur 60 HRCT 60 neurologic deficits 60 Sentinel node biopsy 60 lymphoma subtypes 60 carcinoma 60 hypoechoic 60 fundus photography 60 esophagectomy 60 myelofibrosis polycythemia vera 60 epithelioid 60 breast endometrial 60 multivariate analyzes 60 dose ionizing radiation 60 endoleaks 60 iodixanol 60 cytologically 60 pCLE 60 MR angiography 60 periventricular 60 lesion 60 stratifying patients 60 troponins 60 ERCP 60 hypointense 60 pancreatic ducts 60 CT angiography 60 endometrial biopsy 60 tumor resection 60 Computed Tomography CT scans 60 transabdominal 60 para aortic 60 colorectal cancer CRC 60 prostate cancer PCa 60 ductal breast cancer 60 lateral radiograph 60 oesophagitis 60 mediastinitis 60 hormone receptor negative 60 eccrine 60 MALT lymphoma 60 poorer prognosis 60 venous reflux 60 T2 weighted images 60 myeloproliferative diseases 60 Nasal polyps 60 parathyroid carcinoma 60 computed tomographic scans 60 thoracic aortic aneurysm 60 TIMP 60 urography 60 BRCA mutations 60 clinically insignificant 59 adenomas 59 intraductal 59 mucosal lesions 59 Plain radiographs 59 pleural effusion 59 upper gastrointestinal bleeding 59 Sentinel Lymph Node Biopsy 59 ALA PDT 59 colorectal polyps 59 urolithiasis 59 histologically proven 59 distal colon 59 esophagitis 59 noncalcified 59 microvessel density 59 squamous cell carcinomas 59 androgen suppression 59 hyperbilirubinemia 59 peritumoral 59 calcifications 59 methicillin susceptible Staphylococcus aureus 59 Asymptomatic 59 RECIST Response Evaluation Criteria 59 postoperative infections 59 Endoscopic ultrasound 59 lichen planus 59 venography 59 ProstaScint 59 thyrotropin levels 59 robotic radical prostatectomy 59 INCB# [003] 59 RVOT 59 osteoporotic compression fractures 59 cytoreduction 59 OPCAB 59 coronary anatomy 59 Tumor shrinkage 59 KIT mutations 59 aminotransferases 59 genomic alterations 59 HNSCC 59 gastric cardia 59 liver histology 59 Anaplastic 59 MGd 59 nasopharyngeal carcinoma 59 seroma 59 pathologic 59 PCA3 scores 59 elevated CRP 59 tumors 59 choroidal 59 invasive lobular 59 colorectal carcinomas 59 lymphatic tissue 59 radiographically 59 peritoneal cancer 59 intravitreal injections 59 chemoradiation 59 coronary angiography 59 EGF receptors 59 adjuvant therapies 59 chlamydial infection 59 chemoradiotherapy 59 cortical dysplasia 59 aortic insufficiency 59 disc herniations 59 metastatic lesion 59 IV bisphosphonates 59 microRNA expression 59 coronary CTA 59 artery embolization 59 Tumor Response 59 elevated IOP 59 microvascular disease 59 brain metastases 59 bronchogenic carcinoma 59 situ DCIS 59 postoperative radiotherapy 59 S. aureus isolates 59 systemic toxicity 59 Haptoglobin 59 pyelonephritis 59 BRAF V#E mutation 59 lumbar disc herniation 59 sonographic 59 inflammatory lesions 59 Subgroup analyzes 59 adrenocortical 59 Barrett mucosa 59 renal allograft 59 sinonasal 59 conjunctival hyperemia 59 transarterial 59 cytokeratin 59 bone metastasis 59 polyp detection 59 candidemia 59 gonococcal infection 59 magnetic resonance angiography 59 proctitis 59 monoclonal gammopathy 59 cellularity 59 pleurodesis 59 esophageal carcinoma 59 chromophobe 59 proximal femur 59 endoscopists 59 nonmelanoma 59 metastatic bone 59 pilocytic astrocytomas 59 hypopigmentation 59 enhanced MR angiography 59 nonmelanoma skin cancer 59 basal cell nevus syndrome 59 appendiceal 59 trabeculectomy 59 prostatic adenocarcinoma 59 univariate analysis 59 prostate cancers 59 metastatic malignant melanoma 59 Basal Cell 59 paraganglioma 59 BRCA2 carriers 59 cervical neoplasia 59 Capsule endoscopy 59 MDCT angiography 59 prognostic factors 59 prognostic markers 59 sigmoid colon 59 miRview ™ squamous 59 surgical debulking 59 Sezary syndrome 59 thromboembolic complications 59 underwent coronary angiography 59 Orthostatic hypotension 59 mammographic density 59 urethral stricture 59 perfusion imaging 59 cytologic examination 59 orchitis 59 partial nephrectomy 59 pretest probability 59 MDCTA 59 taxane therapy 59 axillary 59 Coronary artery calcium 59 geographic atrophy 59 gemcitabine Gemzar 59 multidetector row 59 Preoperatively 59 hyperintensity 59 scintigraphy 59 variceal 59 Response Evaluation Criteria 59 Kaplan Meier analysis 59 percutaneous vertebroplasty 59 chromosomal mutations 59 preoperative PSA 59 infiltrating ductal carcinoma 59 pulmonary metastasis 59 submucosa 59 hyperacute 59 sarcosine 59 neuroblastoma tumors 59 intraepithelial 59 BRCA1 mutations 59 total thyroidectomy 59 basal cell cancer 59 genetic polymorphisms 59 keratoplasty 59 TURP 59 nonmetastatic 59 Sonographic 59 Basal cell 59 nephrectomies 59 vesicoureteral reflux 59 amyloid deposition 59 differentially expressed proteins 59 Ebstein anomaly 59 sleeve lobectomy 59 precancer 59 recurrent DVT 59 sulfasalazine 59 histopathologic diagnosis 59 T#I [002] 59 undergone radical prostatectomy 59 Cytogenetic 59 grade gliomas 59 Fine Needle Aspiration 59 antiangiogenic agents 59 graft dysfunction 59 urothelial cancer 59 paracentesis 59 P. malariae 59 Radiofrequency ablation 59 nonobstructive CAD 59 gemcitabine carboplatin 59 atypical nevi 59 hepatitis C genotype 59 lymphopenia 59 carotid artery blockage 59 troponin T 59 Metastases 59 prostate abnormalities 59 Trichophyton rubrum 59 serum urate levels 59 fluorescein angiography 59 lactate dehydrogenase LDH 59 BladderChek 59 non squamous NSCLC 59 bowel polyps 59 endocrine therapies 59 adenoma detection 59 biliary tract cancers 59 colposcopic 59 synovial 59 esophagogastric 59 carcinomatosis 59 Angiographic 59 lung adenocarcinomas 59 EGFR inhibition 59 incisional 59 glaucomatous 59 mTOR inhibitors 59 CT Angiography 59 platelet reactivity 59 neoplastic cells 59 cTnI 59 pseudophakic 59 metastatic melanomas 59 cardiac perfusion 59 periprocedural 59 response pCR 59 clinicopathological 59 fallopian tube carcinoma 59 vestibular schwannomas 59 mediastinum 59 immunocompetent 59 xenograft models 59 etiologies 59 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 58 neoadjuvant therapy 58 coronary calcification 58 hyperintensities 58 cholelithiasis 58 abnormal Pap smears 58 morphometric vertebral fractures 58 needle biopsy 58 spirometric 58 oropharyngeal 58 EGFR expression 58 LV dysfunction

Back to home page